Kilitch Drugs (India) Ltd Surges to All-Time High
Kilitch Drugs (India) Ltd, a microcap pharmaceutical company, has reached an all-time high of Rs. 390 on December 26, 2023, after receiving a 'Hold' rating from MarketsMojo. The stock has outperformed the sector and is currently trading above its moving averages, indicating a positive trend. With a remarkable growth of 135.88% in the past year, the company shows potential for investors in the pharmaceutical industry.
Kilitch Drugs (India) Ltd, a microcap pharmaceutical company, has recently seen a surge in its stock price, reaching an all-time high of Rs. 390 on December 26, 2023. This comes after the company's stock call was given a 'Hold' rating by MarketsMOJO.
The stock has shown a strong performance today, with a new 52-week high and all-time high being hit. However, it has underperformed the sector by -4.37%. The trend has also reversed, with the stock falling after two consecutive days of gains. The day's high was recorded at Rs. 390, while the low was at Rs. 366.55.
Kilitch Drugs (India) Ltd is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in the stock's performance.
In the past year, Kilitch Drugs (India) Ltd has shown a remarkable growth of 135.88%, outperforming the Sensex's performance of 17.67%. This highlights the company's strong performance and potential for growth in the pharmaceutical industry.
As a microcap company, Kilitch Drugs (India) Ltd may not be as well-known as its larger counterparts, but its recent stock performance shows promising growth and potential for investors. With a 'Hold' rating from MarketsMOJO, the company's stock is definitely one to watch in the pharma industry.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
